Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
PASC transplantation (25 million PASCs/patient)The purpose of this study is to assess the safety and efficacy of allogenic pluripotent stem cells isolated from adipose tissue (PASCs) in patients with Parkinson's Disease. Parkinson Phase 1/2 Thérapie cellulaire Costa Rica À vérifier
PASC transplantation (25 million PASCs/patient)The purpose of this study is to assess the safety and efficacy of allogenic pluripotent stem cells isolated from adipose tissue (PASCs) in patients with Parkinson's Disease. Parkinson Phase 1/2 Thérapie cellulaire Costa Rica À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
PASC transplantation (25 million PASCs/patient) Parkinson Phase 1/2 NCT06141317 Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.